本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Orchestra BioMed

2.78
+0.20007.75%
盘后2.780.00000.00%19:59 EDT
成交量:29.23万
成交额:79.34万
市值:1.07亿
市盈率:-1.68
高:2.85
开:2.62
低:2.55
收:2.58
数据加载中...
2025/04/01

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/03

重要事件披露

Form 8-K - Current report
2025/02/26

重要事件披露

Form 8-K - Current report
2025/02/20

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/05

重要事件披露

Form 8-K - Current report
2024/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/09/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/12

重要事件披露

Form 8-K - Current report
2024/08/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/07

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/08/07

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/07/30

重要事件披露

Form 8-K - Current report
2024/07/17

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]